Cartilage in normal and osteoarthritis conditions.

The preservation of articular cartilage depends on keeping the cartilage architecture intact. Cartilage strength and function depend on both the properties of the tissue and on their structural parameters. The main structural macromolecules are collagen and proteoglycans (aggrecan). During life, cartilage matrix turnover is mediated by a multitude of complex autocrine and paracrine anabolic and catabolic factors. These act on the chondrocytes and can lead to repair, remodeling or catabolic processes like those that occur in osteoarthritis. Osteoarthritis is characterized by degradation and loss of articular cartilage, subchondral bone remodeling, and, at the clinical stage of the disease, inflammation of the synovial membrane. The alterations in osteoarthritic cartilage are numerous and involve morphologic and metabolic changes in chondrocytes, as well as biochemical and structural alterations in the extracellular matrix macromolecules.

[1]  Burton B. Yang,et al.  The Folded Modules of Aggrecan G3 Domain Exert Two Separable Functions in Glycosaminoglycan Modification and Product Secretion* , 2002, The Journal of Biological Chemistry.

[2]  P. Roughley,et al.  Studies on the interaction of newly secreted proteoglycan subunits with hyaluronate in human articular cartilage. , 1990, Biochimica et biophysica acta.

[3]  D. Edwards,et al.  Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption , 2005, Arthritis research & therapy.

[4]  J. Pelletier,et al.  Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18. , 1999, Arthritis and rheumatism.

[5]  F. Cicuttini,et al.  Sex and site differences in cartilage development: a possible explanation for variations in knee osteoarthritis in later life. , 2000, Arthritis and rheumatism.

[6]  D. Eyre,et al.  Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. , 1992, The Journal of biological chemistry.

[7]  S. Clarke,et al.  Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. , 2004, Arthritis and rheumatism.

[8]  M. Lotz,et al.  Focal Adhesion Kinase and Mitogen-activated Protein Kinases Are Involved in Chondrocyte Activation by the 29-kDa Amino-terminal Fibronectin Fragment* , 2002, The Journal of Biological Chemistry.

[9]  F. Cicuttini,et al.  Gender differences in knee cartilage volume as measured by magnetic resonance imaging. , 1999, Osteoarthritis and cartilage.

[10]  P. Delmas,et al.  The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. , 2001, Bone.

[11]  J. Bateman.  Genetic aspects of osteoarthritis. , 2004, Seminars in arthritis and rheumatism.

[12]  P. Roughley,et al.  Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. , 1983, The Biochemical journal.

[13]  S. Kondo,et al.  CTGF/Hcs24, a hypertrophic chondrocyte‐specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes , 2002, Journal of cellular physiology.

[14]  J. Raynauld,et al.  Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. , 1998, The Journal of rheumatology.

[15]  G. Homandberg,et al.  Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. , 1998, Osteoarthritis and cartilage.

[16]  R. Kirkpatrick,et al.  Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. , 2000, Osteoarthritis and cartilage.

[17]  J. Pelletier,et al.  Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. , 1997, Arthritis and rheumatism.

[18]  P. Delmas,et al.  Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis , 2004, Annals of the rheumatic diseases.

[19]  J. Mort,et al.  Modulation of the catabolic effects of interleukin‐1β on human articular chondrocytes by transforming growth factor‐β , 1996 .

[20]  G. Homandberg,et al.  Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. , 1994, Archives of biochemistry and biophysics.

[21]  R. Stevenson,et al.  Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. , 2002, American journal of human genetics.

[22]  P. Roughley,et al.  SLRP interaction can protect collagen fibrils from cleavage by collagenases. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[23]  F. Berenbaum,et al.  HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. , 2007, Osteoarthritis and cartilage.

[24]  L. Lohmander,et al.  The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. , 1992, The Journal of clinical investigation.

[25]  R. Moskowitz,et al.  Clinical correlations of osteoarthritis associated with a single-base mutation (arginine519 to cysteine) in type II procollagen gene. A newly defined pathogenesis. , 1994, Arthritis and rheumatism.

[26]  P. Roughley,et al.  The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. , 2006, European cells & materials.

[27]  W. Tasman,et al.  Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Aigner,et al.  Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. , 2002, Osteoarthritis and cartilage.

[29]  T. Ochi,et al.  Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. , 2003, Osteoarthritis and cartilage.

[30]  P. Delmas,et al.  Biomarkers in osteoarthritis , 2003, Current opinion in rheumatology.

[31]  Brown Ra,et al.  The synthesis and accumulation of fibronectin by human articular cartilage. , 1990 .

[32]  F. Cicuttini,et al.  Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. , 2005, Medical hypotheses.

[33]  D. Eyre,et al.  Collagens and cartilage matrix homeostasis. , 2004, Clinical orthopaedics and related research.

[34]  A. Rowan,et al.  Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. , 2006, Arthritis and rheumatism.

[35]  T. Aigner,et al.  Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. , 2004, Clinical and experimental rheumatology.

[36]  W. Maloney,et al.  Stimulation of BMP-2 Expression by Pro-Inflammatory Cytokines IL-1 and TNF-&agr; in Normal and Osteoarthritic Chondrocytes , 2003, The Journal of bone and joint surgery. American volume.

[37]  Kozo Nakamura,et al.  Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10* , 2002, The Journal of Biological Chemistry.

[38]  P. Garnero,et al.  Use of biochemical markers to study and follow patients with osteoarthritis , 2006, Current rheumatology reports.

[39]  P. Roughley,et al.  Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. , 1980, The Journal of biological chemistry.

[40]  L. Ala‐Kokko,et al.  Genetic risk factors for lumbar disc disease , 2002, Annals of medicine.

[41]  Paul G Scott,et al.  Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Roughley,et al.  Link protein can retard the degradation of hyaluronan in proteoglycan aggregates. , 2006, Osteoarthritis and cartilage.

[43]  G. Vaes,et al.  Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.

[44]  D. Bernstein,et al.  Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice1 , 2000, The Journal of Immunology.

[45]  T. Shiomi,et al.  Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF‐induced angiogenesis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[47]  J. Pelletier,et al.  Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. , 2002, The Journal of rheumatology.

[48]  W. B. van den Berg,et al.  Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. , 1997, Arthritis and rheumatism.

[49]  K. Pavelka,et al.  Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein , 2005, Annals of the rheumatic diseases.

[50]  F. De Ceuninck,et al.  Effects of transforming growth factor-β on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro , 2004 .

[51]  S. Santavirta,et al.  Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. , 2002, Arthritis and rheumatism.

[52]  A. Fosang,et al.  The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. , 2002, The Biochemical journal.

[53]  G. D. Hunter,et al.  Essential role for proteinase-activated receptor-2 in arthritis. , 2003, The Journal of clinical investigation.

[54]  P. Roughley,et al.  Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[55]  H. Roos,et al.  Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. , 1996, The Journal of rheumatology.

[56]  M. Currie,et al.  Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. , 2000, Arthritis and rheumatism.

[57]  A. Hollander,et al.  Molecular Interaction and Matrix Assembly , 1998, The Biochemical journal.

[58]  J. Pelletier,et al.  Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site , 2006, Arthritis research & therapy.

[59]  K. Yudoh,et al.  Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β , 2006 .

[60]  J. Pelletier,et al.  Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. , 1996, Arthritis and rheumatism.

[61]  S. Chubinskaya,et al.  Human Articular Chondrocytes Express Osteogenic Protein-1 , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[62]  T. Durand,et al.  The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy. , 2003, Prostaglandins & other lipid mediators.

[63]  P. Garnero,et al.  Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[64]  J. Pelletier,et al.  A novel negative regulatory element in the human collagenase-3 proximal promoter region. , 2002, Biochemical and biophysical research communications.

[65]  M. Takigawa,et al.  Effects of CTGF/Hcs24, a Product of a Hypertrophic Chondrocyte-Specific Gene, on the Proliferation and Differentiation of Chondrocytes in Culture1. , 2000, Endocrinology.

[66]  B. Schmidt-Rohlfing,et al.  Correlation of a novel matrix protein with the degree of cartilage degradation , 2002, Rheumatology International.

[67]  H. Konomi,et al.  Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells , 1989, FEBS letters.

[68]  D. Zurakowski,et al.  Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation , 2001, Gene Therapy.

[69]  J. Pelletier,et al.  Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3 , 2004, Annals of the rheumatic diseases.

[70]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[71]  D. Heinegård,et al.  Cartilage Oligomeric Matrix Protein Shows High Affinity Zinc-dependent Interaction with Triple Helical Collagen* , 1998, The Journal of Biological Chemistry.

[72]  Johanne Martel-Pelletier,et al.  Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. , 2004, Arthritis and rheumatism.

[73]  P. Dieppe,et al.  Biological markers in rheumatoid arthritis. , 1994, Seminars in arthritis and rheumatism.

[74]  I. Otterness,et al.  Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA. , 2001, Journal of immunological methods.

[75]  J. Pelletier,et al.  Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study , 2007, Arthritis research & therapy.

[76]  Y. Okada,et al.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.

[77]  G. Lust,et al.  Synthesis of fibronectin in normal and osteoarthritic articular cartilage. , 1984, Biochimica et biophysica acta.

[78]  P. D. Di Cesare,et al.  Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[79]  M. Wislowska,et al.  Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis , 2005, Clinical Rheumatology.

[80]  P. Byers.  Folding defects in fibrillar collagens. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[81]  T. Ohishi,et al.  Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. , 1994, Arthritis & Rheumatism.

[82]  J. Bateman.  The molecular genetics of inherited cartilage disease. , 2001, Osteoarthritis and Cartilage.

[83]  J. Pelletier,et al.  Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines. , 2002, The Journal of rheumatology.

[84]  T. Burn,et al.  Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4)* , 2000, The Journal of Biological Chemistry.

[85]  J. Pelletier,et al.  Metalloproteases and Their Modulation as Treatment in Osteoarthritis , 2000 .

[86]  E. S. Kimball,et al.  Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease. , 1988, Journal of immunology.

[87]  J. Pelletier,et al.  Identification in human osteoarthritic chondrocytes of proteins binding to the novel regulatory site AGRE in the human matrix metalloprotease 13 proximal promoter. , 2006, Arthritis and rheumatism.

[88]  J. Martel-Pelletier,et al.  Intracellular localisation of galectin-3 has a protective role in chondrocyte survival , 2007, Annals of the rheumatic diseases.

[89]  D. Heinegård,et al.  Cleavage of Fibromodulin in Cartilage Explants Involves Removal of the N-terminal Tyrosine Sulfate-rich Region by Proteolysis at a Site That Is Sensitive to Matrix Metalloproteinase-13* , 2004, Journal of Biological Chemistry.

[90]  J. Pelletier,et al.  The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.

[91]  J. Pelletier,et al.  Human Adult Chondrocytes Express Hepatocyte Growth Factor (HGF) Isoforms but Not HGF: Potential Implication of Osteoblasts on the Presence of HGF in Cartilage , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  W. B. van den Berg,et al.  Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. , 2005, Osteoarthritis and cartilage.

[93]  J. Martel-Pelletier,et al.  Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes , 2006, Annals of the rheumatic diseases.

[94]  J. Pelletier,et al.  Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. , 1994, Arthritis and rheumatism.

[95]  F. Berenbaum,et al.  Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. , 2004, Arthritis and rheumatism.

[96]  J. Pelletier,et al.  Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. , 1999, Arthritis and rheumatism.

[97]  A. Poole,et al.  Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. , 1999, Arthritis and rheumatism.

[98]  J. Pelletier,et al.  IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. , 1996, Osteoarthritis and cartilage.

[99]  Yoshihiko Yamada,et al.  Perlecan is essential for cartilage and cephalic development , 1999, Nature Genetics.

[100]  R. Bank,et al.  Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. , 2001, Arthritis and rheumatism.

[101]  Brian,et al.  Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. , 1993, The Journal of biological chemistry.

[102]  D. Loeuille,et al.  Evidence for a key role of leptin in osteoarthritis. , 2003, Arthritis and rheumatism.

[103]  J. Pelletier,et al.  Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. , 2002, Arthritis and rheumatism.

[104]  R. Smeets,et al.  A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. , 2006, Arthritis and rheumatism.

[105]  J. Pelletier,et al.  Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. , 1991, The Journal of rheumatology.

[106]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. , 2004, The Biochemical journal.

[107]  T. Pufe,et al.  The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. , 2001, Arthritis and rheumatism.

[108]  R. Miehlke,et al.  Presence of small proteoglycan fragments in normal and arthritic human cartilage. , 1992, Arthritis and rheumatism.

[109]  J. Martel-Pelletier,et al.  Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. , 2002, Osteoarthritis and cartilage.

[110]  P. Roughley,et al.  The characterization of versican and its message in human articular cartilage and intervertebral disc , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[111]  F. De Ceuninck,et al.  YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. , 2001, Biochemical and biophysical research communications.

[112]  W. Wilcox,et al.  Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene , 2001, Nature Genetics.

[113]  E. Vignon,et al.  Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. , 2004, Osteoarthritis and cartilage.

[114]  V. Goldberg,et al.  Phenotypic modulation of newly synthesized proteoglycans in human cartilage and chondrocytes. , 1995, Osteoarthritis and cartilage.

[115]  G. Verbruggen,et al.  Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage. , 2003, Arthritis and rheumatism.

[116]  Y. Iwamoto,et al.  Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. , 1999, Endocrinology.

[117]  J. Smolen,et al.  Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. , 2003, Arthritis and rheumatism.

[118]  N. Miosge,et al.  Perlecan in late stages of osteoarthritis of the human knee joint. , 2004, Osteoarthritis and cartilage.

[119]  S. Kumar,et al.  Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. , 2006, Osteoarthritis and cartilage.

[120]  A. Friedl,et al.  Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[121]  P. Roughley,et al.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.

[122]  J. Pelletier,et al.  Extracellular localization of galectin-3 has a deleterious role in joint tissues , 2007, Arthritis research & therapy.

[123]  Claude Kauffmann,et al.  Computer-aided method for quantification of cartilage thickness and volume changes using MRI: validation study using a synthetic model , 2003, IEEE Transactions on Biomedical Engineering.

[124]  G. Kolarz,et al.  Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction , 2004, Arthritis research & therapy.

[125]  D A Bloch,et al.  Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging , 2004, Annals of the rheumatic diseases.

[126]  A. Baici,et al.  Cytoskeletal architecture and cathepsin B trafficking in human articular chondrocytes , 2000, Histochemistry and Cell Biology.

[127]  A. Maroudas,et al.  Methods in cartilage research , 1990 .

[128]  H. Muir,et al.  Hyaluronic acid in human articular cartilage. Age-related changes in content and size. , 1988, The Biochemical journal.

[129]  T. Hardingham,et al.  Studies on the G3 Domain of Aggrecan from Human Cartilage a , 1996, Annals of the New York Academy of Sciences.

[130]  M. Venn.  Chemical composition of human femoral and head cartilage: influence of topographical position and fibrillation. , 1979, Annals of the rheumatic diseases.

[131]  W. Stetler-Stevenson,et al.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. , 1993, The Journal of clinical investigation.

[132]  Gavin C. Jones,et al.  ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis , 2005, Arthritis research & therapy.

[133]  H. Afif,et al.  Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. , 2004 .

[134]  O. Gualillo,et al.  Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1 , 2005, Arthritis research & therapy.

[135]  D. Thompson,et al.  Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. , 2005, Osteoarthritis and cartilage.

[136]  D. Heinegård,et al.  COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. , 1992, The Journal of biological chemistry.

[137]  W. Graninger,et al.  Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. , 2002, Osteoarthritis and cartilage.

[138]  Yoshiaki Toyama,et al.  Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. , 2003, The American journal of pathology.

[139]  B. Swoboda,et al.  Expression of type VI collagen in normal and osteoarthritic human cartilage. , 1999, Osteoarthritis and cartilage.

[140]  A. Fourie,et al.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro , 2005, Nature.

[141]  J. Pelletier,et al.  Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts , 2004 .

[142]  P. Delmas,et al.  Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. , 2001, Rheumatology.

[143]  H. Ma,et al.  Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.

[144]  E. Lechman,et al.  Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. , 2000, Arthritis and rheumatism.

[145]  HighWire Press.  Philosophical Transactions of the Royal Society of London , 1781, The London Medical Journal.

[146]  W. B. van den Berg,et al.  Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. , 1998, Osteoarthritis and cartilage.

[147]  S. Julovi,et al.  COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. , 2004, Rheumatology.

[148]  Y. Muragaki,et al.  The complete primary structure of two distinct forms of human α(IX) collagen chains , 1990 .

[149]  H. V. Van Wart,et al.  Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. , 2000, Arthritis and rheumatism.

[150]  J. Tyler,et al.  Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human articular cartilage. , 1992, Annals of the rheumatic diseases.

[151]  E. Vignon,et al.  Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study , 2000, Annals of the rheumatic diseases.

[152]  E. Zanders,et al.  Amelioration of arthritis in two murine models using antibodies to oncostatin M. , 2001, Arthritis and rheumatism.

[153]  R. Mason,et al.  Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. , 2001, Arthritis and rheumatism.

[154]  D. Xie,et al.  Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. , 1993, Archives of biochemistry and biophysics.

[155]  R. Willburger,et al.  In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. , 1993, Arthritis and rheumatism.

[156]  M. Hochberg,et al.  Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. , 2003, Osteoarthritis and cartilage.

[157]  J. Pelletier,et al.  The Induction of Cell Death in Human Osteoarthritis Chondrocytes by Nitric Oxide Is Related to the Production of Prostaglandin E2 Via the Induction of Cyclooxygenase-2 , 2000, The Journal of Immunology.

[158]  D. Schuppan,et al.  Hepatocyte growth factor in human osteoarthritic cartilage. , 1999, Osteoarthritis and cartilage.

[159]  J. Bijlsma,et al.  Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products* , 2000, The Journal of Biological Chemistry.

[160]  N. Boos,et al.  Immunohistochemical analysis of type X‐collagen expression in osteoarthritis of the hip joint , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[161]  Paul A. C. Cloos,et al.  Cartilage degradation products as markers for evaluation of patients with rheumatic disease , 2004 .

[162]  R. Loeser,et al.  Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures. , 2003, The Journal of rheumatology.

[163]  N. Ishiguro,et al.  Analysis of cartilage-derived retinoic-acid-sensitive protein (CD-RAP) in synovial fluid from patients with osteoarthritis and rheumatoid arthritis. , 2002, The Journal of bone and joint surgery. British volume.

[164]  R. Timpl,et al.  The Leucine-rich Repeat Protein PRELP Binds Perlecan and Collagens and May Function as a Basement Membrane Anchor* , 2002, The Journal of Biological Chemistry.

[165]  S. Miyamoto,et al.  Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis , 2004, Arthritis research & therapy.

[166]  A. Rowan,et al.  Oncostatin M in combination with tumour necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 , 2005, Annals of the rheumatic diseases.

[167]  G. Knutsen,et al.  Human articular chondrocytes express functional leptin receptors. , 2001, Biochemical and biophysical research communications.

[168]  J. Pelletier,et al.  In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis. , 2001, Arthritis and rheumatism.

[169]  A. Zien,et al.  Gene Expression in Chondrocytes Assessed with Use of Microarrays , 2003, The Journal of bone and joint surgery. American volume.

[170]  G. Homandberg,et al.  Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. , 1993, The Journal of rheumatology.

[171]  R. Pichika,et al.  Antisense oligonucleotides to the integrin receptor subunit alpha(5) decrease fibronectin fragment mediated cartilage chondrolysis. , 2002, Osteoarthritis and cartilage.

[172]  D. Hungerford,et al.  Evaluation of thermoreversible polymers containing fibroblast growth factor 9 (FGF-9) for chondrocyte culture. , 2004, Journal of biomedical materials research. Part A.

[173]  J. Martel-Pelletier,et al.  Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. , 2001, Arthritis and rheumatism.

[174]  J. Pelletier,et al.  The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. , 2002, Arthritis and rheumatism.

[175]  P. Roughley,et al.  Ageing and the aggregating proteoglycans of human articular cartilage. , 1986, Clinical science.

[176]  T. Hara,et al.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. , 2000, The American journal of pathology.

[177]  M. Itokazu,et al.  Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis , 2003, Annals of the rheumatic diseases.

[178]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.

[179]  W. B. van den Berg,et al.  Loss of transforming growth factor counteraction on interleukin 1 mediated effects in cartilage of old mice , 2002, Annals of the rheumatic diseases.

[180]  T. Ochi,et al.  Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in the human , 2000, Histochemistry and Cell Biology.

[181]  Albert C. Chen,et al.  Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. , 2002, Arthritis and rheumatism.

[182]  S. Vukicevic,et al.  Expression of bone morphogenetic proteins and cartilage‐derived morphogenetic proteins during osteophyte formation in humans , 2003, Journal of anatomy.

[183]  A. Sieron,et al.  Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[184]  D. Eyre,et al.  Articular cartilage collagen: an irreplaceable framework? , 2006, European cells & materials.

[185]  Alice Maroudas,et al.  Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. , 2002, Arthritis and rheumatism.

[186]  P. Roughley,et al.  Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. , 1995, Arthritis and rheumatism.

[187]  R. Loeser,et al.  Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulate mitogen‐activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes , 2002 .